AIM IMMUNOTECH INC.: current assets
Current assets for AIM IMMUNOTECH INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All AIM IMMUNOTECH INC. financial histories
What this measure means
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
Exact concept: us-gaap:AssetsCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 3,295,000 | USD | 2026-03-27 | 10-K · 0001493152-26-013301 |
| At date | 2024-12-31 | 4,176,000 | USD | 2026-03-27 | 10-K · 0001493152-26-013301 |
| At date | 2023-12-31 | 14,556,000 | USD | 2025-03-27 | 10-K · 0001641172-25-000847 |
| At date | 2022-12-31 | 36,321,000 | USD | 2024-04-01 | 10-K · 0001493152-24-012058 |
| At date | 2021-12-31 | 50,213,000 | USD | 2023-03-31 | 10-K · 0001493152-23-010351 |
| At date | 2020-12-31 | 40,310,000 | USD | 2022-03-31 | 10-K · 0001493152-22-008324 |
| At date | 2019-12-31 | 10,446,000 | USD | 2021-03-31 | 10-K · 0001493152-21-007259 |
| At date | 2018-12-31 | 3,799,000 | USD | 2020-03-30 | 10-K · 0001493152-20-005290 |
| At date | 2017-12-31 | 3,505,000 | USD | 2019-04-01 | 10-K · 0001493152-19-004583 |
| At date | 2016-12-31 | 6,941,000 | USD | 2018-03-30 | 10-K · 0001493152-18-004291 |
| At date | 2015-12-31 | 10,571,000 | USD | 2017-03-31 | 10-K · 0001493152-17-003242 |
| At date | 2014-12-31 | 16,507,000 | USD | 2016-03-29 | 10-K · 0001615774-16-004671 |
| At date | 2013-12-31 | 18,552,000 | USD | 2015-03-19 | 10-K · 0000946644-15-000008 |
| At date | 2012-12-31 | 44,728,000 | USD | 2014-03-14 | 10-K · 0000946644-14-000005 |
| At date | 2011-12-31 | 31,786,000 | USD | 2013-03-18 | 10-K · 0001144204-13-015749 |
| At date | 2010-12-31 | 36,674,000 | USD | 2012-03-14 | 10-K · 0001144204-12-014793 |
Related financial histories
- AIM IMMUNOTECH INC.: total assets
- AIM IMMUNOTECH INC.: total liabilities
- AIM IMMUNOTECH INC.: stockholders equity
- AIM IMMUNOTECH INC.: cash and cash equivalents
- AIM IMMUNOTECH INC.: net income or loss
- AIM IMMUNOTECH INC.: operating cash flow
- AIM IMMUNOTECH INC.: capital expenditure payments
- AIM IMMUNOTECH INC.: revenue
- AIM IMMUNOTECH INC.: contract revenue excluding tax
- AIM IMMUNOTECH INC.: financing cash flow
- AIM IMMUNOTECH INC.: investing cash flow
- AIM IMMUNOTECH INC.: retained earnings or deficit
- AIM IMMUNOTECH INC.: basic weighted-average shares
- AIM IMMUNOTECH INC.: diluted weighted-average shares
- AIM IMMUNOTECH INC.: basic earnings per share
- AIM IMMUNOTECH INC.: diluted earnings per share
- AIM IMMUNOTECH INC.: net property, plant and equipment
- AIM IMMUNOTECH INC.: share-based compensation expense
- AIM IMMUNOTECH INC.: operating income or loss
- AIM IMMUNOTECH INC.: interest expense
- AIM IMMUNOTECH INC.: current liabilities
- AIM IMMUNOTECH INC.: current accounts payable
- AIM IMMUNOTECH INC.: net finite-lived intangible assets
- AIM IMMUNOTECH INC.: net current accounts receivable
- AIM IMMUNOTECH INC.: cost of revenue
- AIM IMMUNOTECH INC.: research and development expense
Inspect the source
- Entity
- AIM IMMUNOTECH INC. / CIK 0000946644
- Captured
- 2026-09-20T05:10:35.627Z
- SEC response SHA-256
afa53ad5ae1b337fce564570fdcdd33eb2021618e07f9401e61eecace732bd67
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000946644.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))